8-Week Atopic Dermatitis (AD) Treatment Study

PHASE3CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

November 27, 2017

Primary Completion Date

August 18, 2018

Study Completion Date

August 18, 2018

Conditions
Atopic Dermatitis Eczema
Interventions
DRUG

Investigational OTC Cream

Investigational Over the Counter (OTC) Cream applied topically, twice daily, for 8 weeks, once in the morning and once in the evening, to atopic dermatitis lesions and whole body as moisturizer.

DRUG

0.05% Desonide

"Rx Steroid applied topically, twice daily, once in the morning and once in the evening, for 8 weeks to all atopic dermatitis lesions.~Placebo Cream applied topically, twice daily, for 8 weeks, once in the morning and once in the evening, to whole body as body moisturizer, except atopic dermatitis lesions."

OTHER

Placebo Cream

Placebo Cream applied topically, twice daily, for 8 weeks, once in the morning and once in the evening, to atopic dermatitis lesions and whole body as body moisturizer.

Trial Locations (2)

27612

Wake Research, LLC, Raleigh

37421

WR (Wake Research) ClinSearch, Chattanooga

All Listed Sponsors
lead

Procter and Gamble

INDUSTRY

NCT03386032 - 8-Week Atopic Dermatitis (AD) Treatment Study | Biotech Hunter | Biotech Hunter